What is the recommended dose of Ancef (cefazolin) for a 10-year-old male weighing 63 pounds with a facial laceration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefazolin (Ancef) Dosing for Pediatric Facial Laceration

For a 10-year-old male weighing 63 pounds (28.6 kg) with a facial laceration, administer cefazolin 25 mg/kg/dose intravenously every 8 hours, which equals approximately 715 mg per dose (can round to 750 mg for practical administration). 1, 2

Weight-Based Calculation

  • Convert weight: 63 pounds = 28.6 kg 1
  • Standard pediatric dosing: For children >1 month of age with skin and soft tissue infections, the recommended dose is 25-50 mg/kg/day divided into 3-4 doses 1, 3
  • For this patient: Using 25 mg/kg per dose every 8 hours = 28.6 kg × 25 mg/kg = 715 mg per dose 1
  • Practical rounding: Round to 750 mg per dose for ease of administration using standard vial concentrations 3

Dosing Frequency and Route

  • Administer every 8 hours (three times daily) for adequate tissue levels 1, 3
  • Intravenous route preferred for facial lacerations to ensure rapid therapeutic levels and prevent potential wound infections 2
  • Alternative: If IV access is problematic, intramuscular administration is acceptable at the same dose 3

Clinical Rationale

  • Cefazolin is the preferred first-generation cephalosporin for skin and soft tissue infections, providing excellent coverage against methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus species, the most common pathogens in traumatic facial lacerations 1, 2
  • Facial wounds carry higher cosmetic significance, making appropriate antibiotic prophylaxis particularly important to prevent infection and scarring 2
  • The 25 mg/kg dose represents the lower end of the pediatric range (25-50 mg/kg/day) and is appropriate for prophylaxis or mild-to-moderate infections 1, 3

Duration of Therapy

  • For uncomplicated facial lacerations: A short course of 24-48 hours is typically sufficient if the wound is properly cleaned and closed 2
  • Extend to 5-7 days only if signs of established infection develop (erythema, purulent drainage, fever) 2

Administration Technique

  • For IV bolus: Reconstitute with Sterile Water for Injection, then further dilute with approximately 5 mL and inject slowly over 3-5 minutes 3
  • For IV infusion: Dilute in 50-100 mL of normal saline or 5% dextrose and infuse over 30 minutes 3
  • Shake vial well after reconstitution and inspect for particulate matter 3

Important Caveats

  • Penicillin allergy: If the patient has a documented penicillin allergy, assess the type and severity before administering cefazolin, as cross-reactivity occurs in approximately 1-3% of cases with IgE-mediated reactions 4
  • Renal function: No dose adjustment needed for normal renal function in this age group 1, 3
  • Pain on injection: Cefazolin causes minimal pain with intramuscular injection compared to other cephalosporins 5, 6

Common Pitfalls to Avoid

  • Do not underdose: Using adult fixed dosing (e.g., 1 gram) without weight-based calculation may result in subtherapeutic levels in smaller children 1
  • Do not extend therapy unnecessarily: Prolonged antibiotic courses beyond clinical need contribute to antimicrobial resistance 2
  • Do not substitute vancomycin routinely: Reserve vancomycin for documented MRSA or true beta-lactam allergy, as cefazolin provides superior coverage for typical skin flora 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cefazolin Dosing for Pediatric Patients with Skin and Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of cefazolin, a new cephalosporin antibiotic.

Antimicrobial agents and chemotherapy, 1973

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.